Cannara Biotech to Host Investor Webcast on Thursday December 19th, 2024 Nicholas Sosiak, CFO, will conduct a presentation that will cover key financial and operational results for the fiscal year ended Auguust 31 2024.

Cannara Biotech Achieves its Highest National Market Share of 3.2% in July 2024 and Announces Investor Webcast Scheduled for August 20, 2024 Cannara Biotech announces record-breaking July revenues and schedules an investor webcast for August 20, 2024. Join at 2 PM ET for Q3 updates and a live QA

Cannara Biotech publie ses résultats financiers pour le troisième trimestre de 2024 Les produits bruts du cannabis avant les taxes d’accise ont augmenté pour atteindre 26,2 millions de dollars au troisième trimestre 2024, contre 20,6 millions de dollars au troisième trimestre 2023,...

Cannara Biotech Reports Q3 2024 Financial Results Net revenues up 22.6% to $19.5M, positive Adjusted EBITDA of $2.8M and operating cash flows of $4.3 million. Focused on the Canadian Cannabis Opportunity

Average Investor Shines, then Sputters at Finish Line Marlborough, MA, April 12, 2018 (GLOBE NEWSWIRE) -- (Marlborough, MA. April 9, 2018) A study by DALBAR, Inc. shows that the average equity fund investor was able to navigate a friendly 2017 market...